SEAZEN (01030): Seazen Holdings (601155.SH) achieved a total commercial operating revenue of approximately 14.09 billion yuan in 2025, a year-on-year increase of 10.00%.
Xin Cheng Development (01030) releases the operating brief for December 2025 and the fourth quarter of New City Holdings Group Co., Ltd. (601155.SH). Total commercial operating revenue in December reached approximately 1.238 billion yuan, an increase of 6.44% compared to the same period last year; total commercial operating revenue for the period of 1-12 months reached approximately 14.09 billion yuan, an increase of 10.00% compared to the same period last year.
Seazen (01030) has released an operational report for Seazen Holdings Group Limited (601155.SH) for December 2025 and the fourth quarter. Total commercial operating revenue in December was approximately 1.238 billion yuan, an increase of 6.44% compared to the same period last year. For the period of January to December, total commercial operating revenue reached around 14.09 billion yuan, an increase of 10.00% compared to the same period last year.
In December, contract sales amounted to approximately 1.354 billion yuan, a decrease of 57.80% compared to the same period last year. Sales area was around 184,300 square meters, a decrease of 51.34% compared to the same period last year. For the cumulative period of December, contract sales totaled approximately 19.27 billion yuan, a decrease of 52.03% compared to the same period last year. The cumulative sales area was about 2.536 million square meters, a decrease of 52.94% compared to the same period last year.
Related Articles

HK Bull/Bear Outstanding Qty Ratio(68:32) | January 10th

Overnight US stocks | S&P 500 index hits new all-time high, Intel Corporation (INTC.US) rises 10.8%

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.
HK Bull/Bear Outstanding Qty Ratio(68:32) | January 10th

Overnight US stocks | S&P 500 index hits new all-time high, Intel Corporation (INTC.US) rises 10.8%

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


